Prevalence of methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii in a long-term acute care facility
- PMID: 18786448
- PMCID: PMC2853910
- DOI: 10.1016/j.ajic.2008.01.003
Prevalence of methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii in a long-term acute care facility
Abstract
Background: Patients in long-term acute care (LTAC) facilities often have many known risk factors for acquisition of antibiotic-resistant bacteria. However, the prevalence of resistance in these facilities has not been well described.
Methods: We performed a single-day, point-prevalence study of a 180-bed, university-affiliated LTAC facility in Baltimore to assess the prevalence of methicillin-resistant Staphylococcus aureus (MRSA) and Acinetobacter baumannii in the anterior nares, perirectal area, sputum, and wounds.
Results: Among the 147 patients evaluated, we found a high prevalence of colonization by both MRSA (28%) and A baumannii (30%). Of the A baumannii isolates, 90% were susceptible to imipenem and 92% were susceptible to ampicillin-sulbactam. No isolates were resistant to both imipenem and ampicillin-sulbactam.
Conclusion: The high prevalence of resistance found in this study supports the need for increased surveillance of patients in the LTAC environment. The fact that these patients are often frequently transferred to tertiary care facilities also supports the need for coordination and collaboration among facilities within the same health care system and the broader geographic area.
Similar articles
-
Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU.BMC Infect Dis. 2020 Sep 1;20(1):646. doi: 10.1186/s12879-020-05374-z. BMC Infect Dis. 2020. PMID: 32873235 Free PMC article.
-
Aggressive control measures for resistant Acinetobacter baumannii and the impact on acquisition of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in a medical intensive care unit.Infect Control Hosp Epidemiol. 2004 Feb;25(2):167-8. doi: 10.1086/502370. Infect Control Hosp Epidemiol. 2004. PMID: 14994945
-
A prospective multicenter study on the evaluation of antimicrobial resistance and molecular epidemiology of multidrug-resistant Acinetobacter baumannii infections in intensive care units with clinical and environmental features.Ann Clin Microbiol Antimicrob. 2019 Jul 2;18(1):19. doi: 10.1186/s12941-019-0319-8. Ann Clin Microbiol Antimicrob. 2019. PMID: 31266519 Free PMC article.
-
[Muco-cutaneous colonization and nosocomial infections caused by methicillin-resistant Staphylococcus aureus and Acinetobacter baumanii in intensive care patients].Pathol Biol (Paris). 2000 Jul;48(6):533-40. Pathol Biol (Paris). 2000. PMID: 10965530 French.
-
Comparison of trends of resistance rates over 3 years calculated from results for all isolates and for the first isolate of a given species from a patient.J Clin Microbiol. 2004 Oct;42(10):4776-9. doi: 10.1128/JCM.42.10.4776-4779.2004. J Clin Microbiol. 2004. PMID: 15472340 Free PMC article.
Cited by
-
Effects of Staphylococcus aureus on stem cells and potential targeted treatment of inflammatory disorders.Stem Cell Res Ther. 2024 Jun 27;15(1):187. doi: 10.1186/s13287-024-03781-6. Stem Cell Res Ther. 2024. PMID: 38937829 Free PMC article. Review.
-
Chlorhexidine and mupirocin susceptibilities of methicillin-resistant staphylococcus aureus from colonized nursing home residents.Antimicrob Agents Chemother. 2013 Jan;57(1):552-8. doi: 10.1128/AAC.01623-12. Epub 2012 Nov 12. Antimicrob Agents Chemother. 2013. PMID: 23147721 Free PMC article.
-
Nosocomial Outbreak of Extensively Drug-Resistant Acinetobacter baumannii Isolates Containing blaOXA-237 Carried on a Plasmid.Antimicrob Agents Chemother. 2017 Oct 24;61(11):e00797-17. doi: 10.1128/AAC.00797-17. Print 2017 Nov. Antimicrob Agents Chemother. 2017. PMID: 28893775 Free PMC article.
-
Frequent multidrug-resistant Acinetobacter baumannii contamination of gloves, gowns, and hands of healthcare workers.Infect Control Hosp Epidemiol. 2010 Jul;31(7):716-21. doi: 10.1086/653201. Infect Control Hosp Epidemiol. 2010. PMID: 20486855 Free PMC article.
-
Epidemiology of bloodstream infections caused by Acinetobacter baumannii and impact of drug resistance to both carbapenems and ampicillin-sulbactam on clinical outcomes.Antimicrob Agents Chemother. 2013 Dec;57(12):6270-5. doi: 10.1128/AAC.01520-13. Epub 2013 Oct 7. Antimicrob Agents Chemother. 2013. PMID: 24100492 Free PMC article.
References
-
- Eskildsen MA. Long-term acute care: a review of the literature. J Am Geriatr Soc. 2007;55:775–9. - PubMed
-
- Furuno JP, McGregor JC, Harris AD, Johnson JA, Johnson JK, Langenberg P, et al. Identifying groups at high risk for carriage of antibiotic-resistant bacteria. Arch Intern Med. 2006;166:580–5. - PubMed
-
- McGregor JC, Perencevich EN, Furuno JP, Langenberg P, Flannery K, Zhu J, et al. Comorbidity risk-adjustment measures were developed and validated for studies of antibiotic-resistant infections. J Clin Epidemiol. 2006;59:1266–73. - PubMed
-
- Clinical modification. 6. Los Angeles, CA: Practice Management Information Corp; 2006. International classification of diseases, 9th revision.
Publication types
MeSH terms
Substances
Grants and funding
- K12 RR023250/RR/NCRR NIH HHS/United States
- K23 AI01752-01A1/AI/NIAID NIH HHS/United States
- 1K12RR02350-01/RR/NCRR NIH HHS/United States
- R01 AI60859-01A1/AI/NIAID NIH HHS/United States
- K12 RR023250-01/RR/NCRR NIH HHS/United States
- K23 AI001752/AI/NIAID NIH HHS/United States
- R01 AI060859-01A1/AI/NIAID NIH HHS/United States
- P60 AG12583/AG/NIA NIH HHS/United States
- R01 AI060859/AI/NIAID NIH HHS/United States
- K24 AI079040/AI/NIAID NIH HHS/United States
- K23 AI001752-01A1/AI/NIAID NIH HHS/United States
- P60 AG012583/AG/NIA NIH HHS/United States